🔎 Trials Near Me

Home › Leiomyosarcoma › Illinois

Leiomyosarcoma clinical trials in Illinois

4 studies for Leiomyosarcoma are looking for participants at sites in Illinois.

Cities in Illinois

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago MBCCOP, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT04031677

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • University of Chicago Comprehensive Cancer Center, Chicago
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox
  • University of Chicago Medicine-Orland Park, Orland Park
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

  • Northwestern University, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06571734

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.